Karl Gibson, PhD

Head of Medicinal Chemistry

Orexia Therapeutics

Karl Gibson, PhD, serves as Head of Medicinal Chemistry at Orexia Therapeutics. Prior to joining Orexia, Karl spent five years as a Medicinal Chemist at Merck & Co., Inc. Neuroscience Research Center followed by nine years at Pfizer, leading Medicinal Chemistry teams across the Pain, Urology and Infectious Disease therapeutic areas.

In 2011, Karl co-founded Sandexis Medicinal Chemistry. Since then, he has provided Medicinal Chemistry leadership and design to a number of biotech companies and programs.

Karl obtained his PhD in Chemistry from the University of Cambridge.

Read more here about Orexia Therapeutics

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser